Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jul 12;17(9):3326-3330.
doi: 10.1016/j.radcr.2022.06.034. eCollection 2022 Sep.

A severe presentation of breakthrough infection caused by the Omicron variant with radiological findings of COVID-19 pneumonia in an elderly woman

Affiliations
Case Reports

A severe presentation of breakthrough infection caused by the Omicron variant with radiological findings of COVID-19 pneumonia in an elderly woman

Barbara Brogna et al. Radiol Case Rep. .

Abstract

Omicron variant of COVID-19 is characterized by exceptional transmissibility and by immune evasion with the ability infect people with naturally acquired or vaccine-induced immunity. However, lung involvement is poorly reported in patients who resulted positive by this new COVID-19 variant. COVID-19 breakthrough infections are defined as COVID-19 infection in fully vaccinated patients. Herein, we present a case of breakthrough infection in an elderly woman who came in emergency with dyspnea and with findings of COVID-19 pneumonia on chest computed tomography. The patient was vaccinated with a booster dose of an mRNA vaccine some months earlier and the Omicron variant was detected on real-time reverse-transcription polymerase chain reaction. However, the patient's condition remained stable. For our knowledge we report the first case with lung involvement due to Omicron variant in an elderly after the booster dose of mRNA vaccine. This case highlights as COVID-19 breakthrough infections may represent some concerns in the elderly patients in presence of virus variants.

Keywords: COVID-19; Elderly; Immunosenescence; Omicron variant; Vaccines.

PubMed Disclaimer

Figures

Fig 1 –
Fig. 1
Chest CT performed at the baseline. In the images “a” and “b”, and “c” is represented the COVID-19 pneumonia with interstitial thickness with GGOs and initial consolidations in a multifocal distributions in the superior and inferior lobes with a predominance on the right side on the axial plane, in the image “d” on the coronal plane.
Fig 2 –
Fig. 2
Chest-CT performed 1 week later. In the image “a” and “b” is represented a more pronounced consolidations of the COVID-19 pneumonia in the superior lobes with a mild pleural effusion on the right side (yellow arrow).
Fig 3 –
Fig. 3
Chest CT performed after other 10 days that showed a mild reduction of the consolidations areas with increased appearance of the right pleural effusion (yellow arrow in the image a and b) and a small pleural effusion also on the left side (yellow arrow in the image b).

Similar articles

Cited by

References

    1. Tsai P.H., Lai W.Y., Lin Y.Y., Luo Y.H., Lin Y.T., Chen H.K., et al. Clinical manifestation and disease progression in COVID-19 infection. J Chin Med Assoc. 2021;84:3–8. doi: 10.1097/JCMA.0000000000000463. - DOI - PubMed
    1. El-Shabasy R.M., Nayel M.A., Taher M.M., Abdelmonem R., Shoueir K.R., Kenawy E.R. Three wave changes, new variant strains, and vaccination effect against COVID-19 pandemic. Int J Biol Macromol. 2022;204:161–168. doi: 10.1016/j.ijbiomac.202201118. - DOI - PMC - PubMed
    1. Behzad S., Aghaghazvini L., Radmard A.R., Gholamrezanezhad A. Extrapulmonary manifestations of COVID-19: radiologic and clinical overview. Clin Imaging. 2020;66:35–41. doi: 10.1016/j.clinimag.202005013. - DOI - PMC - PubMed
    1. Kamal, M., Abo Omirah, M., Hussein, A., Saeed, H. Assessment and characterisation of post-COVID-19 manifestations. Int J ClinPract2020, 75, 3, e13746; doi:10.1111/ijcp.13746. - DOI - PMC - PubMed
    1. Voysey M., Clemens S.A.C., Madhi S.A., Weckx L.Y., Folegatti P.M., Aley P.K., et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2020;9:99–111. doi: 10.1016/S0140-6736(20)32661-1. - DOI - PMC - PubMed

Publication types

LinkOut - more resources